Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
35,10 EUR | -0,43% | +8,00% | -17,10% |
06/09 | DERMAPHARM : Jefferies nog altijd een koopadvies | ZD |
03/09 | DERMAPHARM : Jefferies bevestigt koopadvies | ZD |
Toevoegen aan een lijst 0 geselecteerde | Omzet ($) (Y-1) | Nettomarge (Y-1) | Bedrijfsmarge (Y-1) | ROE (Y-1) | ROA (Y-1) | Hefboom (schuld/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
1,26 mld. | +5.49% | +16.11% | +11.65% | - | 3.02x | ||
34,12 mld. | +15.36% | +20.68% | +48.93% | +9.23% | 2.6x | ||
34,61 mld. | +36.03% | +44.16% | +88.07% | +30.12% | -0.03x | ||
85,16 mld. | +41.28% | +32.25% | +34.91% | +14.32% | 0.21x | ||
54,32 mld. | +8.95% | +45.64% | +143.18% | +14.46% | 1.82x | ||
60,12 mld. | +0.61% | +10.33% | +9.18% | +3.56% | 2.77x | ||
69,34 mld. | +19.58% | +32.77% | +45.73% | +16.71% | 0.85x | ||
45,81 mld. | +13.01% | +31.73% | +29.77% | +11.48% | 1.66x | ||
45,44 mld. | +32.69% | +36.03% | +25.37% | +12.37% | 0.67x | ||
28,19 mld. | +23.83% | +47.53% | +202.85% | +12.37% | 3.07x | ||
58,5 mld. | +3.62% | +15.90% | +11.37% | +4.96% | 3.8x | ||
47,88 mld. | +12.54% | +29.42% | +13.65% | +4.27% | 0.55x | ||
27,12 mld. | +20.89% | +38.66% | +38.46% | +13.49% | 1.34x | ||
45,01 mld. | +17.83% | +37.30% | +51.57% | +8.36% | 1.55x | ||
39,93 mld. | +16.25% | +28.97% | +52.48% | +10.55% | 1.29x | ||
7,84 mld. | +29.29% | +39.52% | +21.30% | +23.34% | -1.57x | ||
11,3 mld. | +12.53% | +13.21% | +12.80% | +7.95% | -2.01x | ||
14,88 mld. | +9.28% | +22.55% | +6.37% | +3.05% | 3.01x | ||
30,08 mld. | +3.38% | +5.02% | +2.10% | +0.36% | 4.66x | ||
Gemiddelde | 39 mld. | +16,97% | +28,83% | +44,72% | +11,16% | 1,54x | |
Gewogen gemiddelde per kap. | 46,24 mld. | +20,29% | +30,95% | +56,92% | +13,43% | 1,47x |
- Beurs
- Aandelen
- Koers DMP
- Sector Dermapharm Holding SE
- Financiële vergelijkingen